Cargando…

Disease characteristics and outcomes in patients with chronic kidney disease and type 2 diabetes: a matched cohort study of spironolactone users and non-users

BACKGROUND: Limited evidence has indicated that addition of a steroidal mineralocorticoid receptor antagonist (MRA) to the standard of care reduces proteinuria in patients with diabetic kidney disease (DKD); however, there are limited data regarding real-world MRA use in these patients. This study a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Blankenburg, Michael, Kovesdy, Csaba P., Fett, Anne-Kathrin, Griner, Raymond G., Gay, Alain
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045439/ https://www.ncbi.nlm.nih.gov/pubmed/32101152 http://dx.doi.org/10.1186/s12882-020-01719-7

Ejemplares similares

Patient characteristics and initiation of mineralocorticoid receptor antagonists in patients with chronic kidney disease in routine clinical practice in the US: a retrospective cohort study
por: Blankenburg, Michael, et al.
Publicado: (2019)

Chronic kidney disease progression among patients with type 2 diabetes identified in US administrative claims: a population cohort study
por: Kovesdy, Csaba P, et al.
Publicado: (2020)

Annual health care resource utilization and cost among type 2 diabetes patients with newly recognized chronic kidney disease within a large U.S. administrative claims database
por: Folkerts, Kerstin, et al.
Publicado: (2020)

A comparative post hoc analysis of finerenone and spironolactone in resistant hypertension in moderate-to-advanced chronic kidney disease
por: Agarwal, Rajiv, et al.
Publicado: (2022)

Changing the paradigms for the treatment of chronic kidney disease
por: Coyne, Daniel W., et al.
Publicado: (2017)

Spironolactone use and risk of incident cancers: a retrospective, matched cohort study
por: Mackenzie, Isla S., et al.
Publicado: (2016)

Wasting in chronic kidney disease
por: Mak, Robert H., et al.
Publicado: (2011)

Long-Term Effects of Spironolactone on Kidney Function and Hyperkalemia-Associated Hospitalization in Patients with Chronic Kidney Disease
por: Yang, Chen-Ta, et al.
Publicado: (2018)

Obesity and kidney disease: Hidden consequences of the epidemic
por: Kovesdy, Csaba P., et al.
Publicado: (2017)

Erratum to: Wasting in chronic kidney disease
por: Mak, Robert H., et al.
Publicado: (2011)

Obesity and kidney disease: Hidden consequences of the epidemic
por: Kovesdy, Csaba P., et al.
Publicado: (2017)

Obesity and kidney disease: hidden consequences of the epidemic
por: Kovesdy, Csaba P., et al.
Publicado: (2017)

Obesity and Kidney Disease: Hidden Consequences of the Epidemic
por: Kovesdy, Csaba P., et al.
Publicado: (2017)

Obesity and kidney disease: hidden consequences of the epidemic
por: Kovesdy, Csaba P, et al.
Publicado: (2017)

Spironolactone in cardiovascular disease: an expanding universe?
por: Funder, John W.
Publicado: (2017)

Kidney Function Change and All-Cause Mortality in Denosumab Users with and without Chronic Kidney Disease
por: Wu, Ping-Hsun, et al.
Publicado: (2022)

Dual Users and Electronic Cigarette Only Users: Consumption and Characteristics
por: Lee, Alexander S., et al.
Publicado: (2018)

Evidence of chronic kidney disease in veterans with incident diabetes mellitus
por: Gatwood, Justin, et al.
Publicado: (2018)

Effect of Spironolactone on Diabetic Nephropathy Compared to the Combination of Spironolactone and Losartan
por: Makhlough, Atieh, et al.
Publicado: (2014)

Spironolactone and risk of incident breast cancer in women older than 55 years: retrospective, matched cohort study
por: Mackenzie, Isla S, et al.
Publicado: (2012)

Risk of New-Onset Dementia in Patients with Chronic Kidney Disease on Statin Users: A Population-Based Cohort Study
por: Jong, Gwo-Ping, et al.
Publicado: (2023)

Topical Spironolactone in the Treatment of Evaporative Dry Eye Disease
por: Wong, Calvin W, et al.
Publicado: (2023)

Evaluation of anticardiolipin antibodies in tobacco users and non-tobacco users with severe chronic periodontal disease
por: Yadalam, Pradeep K., et al.
Publicado: (2016)

Cardiorenal syndrome and vitamin D receptor activation in chronic kidney disease()
por: Darabian, Sirous, et al.
Publicado: (2012)

Patient empowerment through a user-centered design of an electronic personal health record: a qualitative study of user requirements in chronic kidney disease
por: Toni, Esmaeel, et al.
Publicado: (2021)

Predictors of cardio-kidney complications and treatment failure in patients with chronic kidney disease and type 2 diabetes treated with SGLT2 inhibitors
por: Kovesdy, Csaba, et al.
Publicado: (2022)

The impact of user characteristics of smallholder farmers on user experiences with collaborative map applications
por: Bartling, Mona, et al.
Publicado: (2022)

Spironolactone Improves the All-Cause Mortality and Re-Hospitalization Rates in Acute Myocardial Infarction with Chronic Kidney Disease Patients
por: Qu, Xiang, et al.
Publicado: (2021)

Blocking mineralocorticoid receptor with spironolactone may have a wide range of therapeutic actions in severe COVID-19 disease
por: Liaudet, Lucas, et al.
Publicado: (2020)

Real-world evidence for steroidal mineralocorticoid receptor antagonists in patients with chronic kidney disease
por: Folkerts, Kerstin, et al.
Publicado: (2022)

Cognitive test performance in chronic cannabis flower users, concentrate users, and non-users
por: Cuttler, Carrie, et al.
Publicado: (2023)

Survival and mortality among users and non-users of hydroxyurea with sickle cell disease
por: de Araujo, Olinda Maria Rodrigues, et al.
Publicado: (2015)

Low‐protein diet for conservative management of chronic kidney disease: a systematic review and meta‐analysis of controlled trials
por: Rhee, Connie M., et al.
Publicado: (2017)

Use of fenofibrate on cardiovascular outcomes in statin users with metabolic syndrome: propensity matched cohort study
por: Kim, Nam Hoon, et al.
Publicado: (2019)

High Mortality Rate in Oral Glucocorticoid Users: A Population-Based Matched Cohort Study
por: Einarsdottir, Margret J., et al.
Publicado: (2022)

Tool Embodiment: The Tool’s Output Must Match the User’s Input
por: Weser, Veronica, et al.
Publicado: (2019)

Topical Spironolactone in the Treatment of Ocular Graft-Versus-Host Disease
por: Wong, Calvin W, et al.
Publicado: (2023)

Clinical Characteristics and Angiographic Findings of Myocardial Infarction among Marijuana Users and Non-Users
por: Lee, Justin, et al.
Publicado: (2017)

Characteristics and Attitudes of Wearable Device Users and Non-Users in a Large Healthcare System
por: Venn, Rachael A., et al.
Publicado: (2023)

Prevalence of anaemia in adults with chronic kidney disease in a representative sample of the United States population: analysis of the 1999–2018 National Health and Nutrition Examination Survey
por: Kovesdy, Csaba P, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3io2uuehlvj3j5ule1i3mfe6hf